LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming video membership; dose decisions managed on a smartphone app; access made as easy as buying a pair of Nikes. This is their vision of the consumerization of weight-loss as drugmakers Novo Nordisk and Eli Lilly prepare to launch pill versions alongside their blockbuster injectable treatments and incr

Health disparities cost society billions of dollars, and their effects ripple across communities.

A helpful guide on which new releases to watch, including movies in theaters, on streaming or available to rent or buy on digital and on-demand.